Plasma biomarkers
MS-based proteomics is particularly well-suited for identifying specifically and measuring accurately the abundance of protein biomarker candidates. During the last quinquennial period, EDyP team has implemented and optimized an integrated pipeline
This biomarker development pipeline was harnessed internally to complete research projects in the field of hepatology (Dr Virginie Brun and Dr Michel Jaquinod). Particularly, the protein ADH1B was identified and confirmed as a new biomarker the prognosis of acute liver failure [patent PCT/FR2017/050089; Pailleux et al., submitted]
EDyP project leader
Virginie Brun
CEA Researcher
EDyP Director
Image credit: Arek Socha de Pixabay